Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Forgent Power Solutions Inc. Class A Common Stock (FPS) vs Repligen Corporation Common Stock (RGEN) Price & Performance

Forgent Power Solutions Inc. Class A Common StockTrade
Repligen Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Forgent Power Solutions Inc. Class A Common Stock vs Repligen Corporation Common Stock — how do they compare? Forgent Power Solutions Inc. Class A Common Stock trades at $31.52 (market cap $8.98B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Forgent Power Solutions Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Forgent Power Solutions Inc. Class A Common Stock for 0 Days and Repligen Corporation Common Stock for 0 Days on average.

FPSRGEN
Market Cap
$8.98B$11.31B
Volume
7,398,2171,216,919
Sector
IndustrialsHealth
52-Week High
$64.59$194.57
52-Week Low
$27.97$102.87
Typical Hold Time
0 Days0 Days
Enterprise Value
$9.58B$11.20B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Forgent Power Solutions Inc. Class A Common Stock

Forgent Power Solutions (FPS) trades at $36.17, down 2.48% on the day, following a strong earnings-driven rally. The stock shows neutral technical signals with support at $35 and resistance at $37. Recent Q2 2026 earnings beat expectations with EPS of $0.25 versus $0.24 expected, continuing a pattern of quarterly outperformance. The company reported record $3 billion backlog and strong data center demand driving growth.

FPS presents significant upside potential with analyst consensus target of $55.20 (52.9% upside) and 85.7% buy ratings. However, high valuation multiples (P/E 120.57, P/S 6.21) and negative 2025 net income of -$6.17M create valuation concerns. Key risks include execution on $3B backlog and potential overvaluation amid AI infrastructure hype.

Repligen Corporation Common Stock

RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.

Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FPS
100% Buy0% Sell
Avg holding period · 0 Days
RGEN
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Forgent Power Solutions Inc. Class A Common Stock

Forgent Power Solutions designs and manufactures electrical distribution equipment, including transformers, switchgear, transfer switches, and prefabricated power systems, for data centers, the power grid, and industrial facilities, manufacturing across multiple product categories in-house through a network of manufacturing campuses in US.

Read more on FPS →

About Repligen Corporation Common Stock

Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.

Read more on RGEN →